Active ingredient description

Alglucerase was a biopharmaceutical drug for the treatment of Gaucher’s disease. It was a modified form of human β-glucocerebrosidase enzyme, where the non-reducing ends of the oligosaccharide chains have been terminated with mannose residues.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB01

Chemical formula: C₂₅₃₂H₃₈₅₄N₆₇₂O₇₁₁S₁₆

External identifiers

CAS Substance: 143003-46-7
DrugBank Drug: DB00088
RxNorm Ingredient: 46049
SNOMED-CT Concept: 329497002
Alglucerase (substance)
UNII Identifier: 27T56C7KK0